Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
British Journal of Cancer
|
June 1, 1991
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon
S P Langdon, G J Rabiasz, L Anderson, et al.
British Journal of Cancer
|
May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
A H Sims, A J M Zweemer, Y Nagumo, et al.
Radiation Oncology (London, England)
|
April 17, 2019
Development and characterisation of acquired radioresistant breast cancer cell lines
Mark Gray, Arran K Turnbull, Carol Ward, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Breast Cancer Research : BCR
|
June 24, 2010
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer
Karen J Taylor, Andrew H Sims, Liang Liang, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
October 28, 2018
Biocompatibility of common implantable sensor materials in a tumor xenograft model
Mark E Gray, James Meehan, Ewen O Blair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2011
Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies
Dana Faratian, Annelien J M Zweemer, Yoko Nagumo, et al.
Frontiers in Oncology
|
May 12, 2020
Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
James Meehan, Mark Gray, Carlos Martínez-Pérez, et al.
British Journal of Cancer
|
March 31, 1999
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
B J Simpson, J M Bartlett, K G Macleod, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
British Journal of Cancer
|
June 1, 1991
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon
S P Langdon, G J Rabiasz, L Anderson, et al.
British Journal of Cancer
|
May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
A H Sims, A J M Zweemer, Y Nagumo, et al.
Radiation Oncology (London, England)
|
April 17, 2019
Development and characterisation of acquired radioresistant breast cancer cell lines
Mark Gray, Arran K Turnbull, Carol Ward, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Breast Cancer Research : BCR
|
June 24, 2010
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer
Karen J Taylor, Andrew H Sims, Liang Liang, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
October 28, 2018
Biocompatibility of common implantable sensor materials in a tumor xenograft model
Mark E Gray, James Meehan, Ewen O Blair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2011
Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies
Dana Faratian, Annelien J M Zweemer, Yoko Nagumo, et al.
Frontiers in Oncology
|
May 12, 2020
Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
James Meehan, Mark Gray, Carlos Martínez-Pérez, et al.
British Journal of Cancer
|
March 31, 1999
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
B J Simpson, J M Bartlett, K G Macleod, et al.
Page
of 18